# | Title | Journal | Year | Citations |
---|
1 | Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040 | Ophthalmology | 2014 | 4,514 |
2 | Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050 | Ophthalmology | 2016 | 2,684 |
3 | Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales | Ophthalmology | 2003 | 2,664 |
4 | Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs—An Extension of the Modified Airlie House Classification | Ophthalmology | 1991 | 2,160 |
5 | Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration | Ophthalmology | 2012 | 1,947 |
6 | Prevalence of Age-related Maculopathy | Ophthalmology | 1992 | 1,699 |
7 | Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration | Ophthalmology | 2012 | 1,550 |
8 | Ranibizumab for Diabetic Macular Edema | Ophthalmology | 2012 | 1,392 |
9 | Early Photocoagulation for Diabetic Retinopathy | Ophthalmology | 1991 | 1,327 |
10 | Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema | Ophthalmology | 2010 | 1,276 |
11 | Imaging of Macular Diseases with Optical Coherence Tomography | Ophthalmology | 1995 | 1,222 |
12 | The RESTORE Study | Ophthalmology | 2011 | 1,212 |
13 | Clinical Classification of Age-related Macular Degeneration | Ophthalmology | 2013 | 1,212 |
14 | Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study | Ophthalmology | 2009 | 1,179 |
15 | Predictors of Long-term Progression in the Early Manifest Glaucoma Trial | Ophthalmology | 2007 | 1,176 |
16 | Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration | Ophthalmology | 2006 | 1,148 |
17 | Photocoagulation Treatment of Proliferative Diabetic Retinopathy | Ophthalmology | 1981 | 1,099 |
18 | The Wisconsin Age-related Maculopathy Grading System | Ophthalmology | 1991 | 1,072 |
19 | Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the atherosclerosis risk in communities study11The authors have no proprietary interest in the equipment and techniques described in this article. | Ophthalmology | 1999 | 1,070 |
20 | Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery | Ophthalmology | 2001 | 1,065 |
21 | Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group | Ophthalmology | 1991 | 1,042 |
22 | Prevalence of Age-related Maculopathy in Australia | Ophthalmology | 1995 | 992 |
23 | Limbal Autograft Transplantation for Ocular Surface Disorders | Ophthalmology | 1989 | 983 |
24 | Intravitreal triamcinolone for refractory diabetic macular edema | Ophthalmology | 2002 | 982 |
25 | Survey of 1264 patients with orbital tumors and simulating lesions | Ophthalmology | 2004 | 968 |
26 | Survey of 520 Eyes with Uveal Metastases | Ophthalmology | 1997 | 959 |
27 | Outdoor Activity Reduces the Prevalence of Myopia in Children | Ophthalmology | 2008 | 944 |
28 | Uveal Melanoma: Trends in Incidence, Treatment, and Survival | Ophthalmology | 2011 | 939 |
29 | Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion | Ophthalmology | 2010 | 938 |
30 | Risk factors for age-related macular degeneration | Ophthalmology | 2001 | 927 |
31 | Ranibizumab for Macular Edema following Central Retinal Vein Occlusion | Ophthalmology | 2010 | 911 |
32 | Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema | Ophthalmology | 2014 | 909 |
33 | Prevalence of Glaucoma | Ophthalmology | 1992 | 899 |
34 | The Five-year Incidence and Progression of Age-related Maculopathy | Ophthalmology | 1997 | 888 |
35 | Automated Identification of Diabetic Retinopathy Using Deep Learning | Ophthalmology | 2017 | 872 |
36 | Prevalence of Open-angle Glaucoma in Australia | Ophthalmology | 1996 | 861 |
37 | The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction, and Macular Hole | Ophthalmology | 2013 | 855 |
38 | Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON | Ophthalmology | 2013 | 854 |
39 | The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia | Ophthalmology | 2010 | 852 |
40 | Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision) | Ophthalmology | 2016 | 839 |
41 | The relationship between glaucoma and myopia | Ophthalmology | 1999 | 827 |
42 | Fundus Photographic Risk Factors for Progression of Diabetic Retinopathy | Ophthalmology | 1991 | 820 |
43 | Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease11Reprint requests to: Linda Lewis, 575 Anton Blvd, Suite 900, Costa Mesa, CA 92626. | Ophthalmology | 2000 | 792 |
44 | Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery | Ophthalmology | 1980 | 789 |
45 | Risk factors associated with age-related macular degeneration | Ophthalmology | 2000 | 789 |
46 | Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion | Ophthalmology | 2010 | 772 |
47 | Visual Acuity and the Causes of Visual Loss in Australia | Ophthalmology | 1996 | 758 |
48 | The Wisconsin Epidemiologic Study of Diabetic Retinopathy | Ophthalmology | 1984 | 731 |
49 | Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema | Ophthalmology | 2016 | 731 |
50 | The Prevalence of Age-related Maculopathy in the Rotterdam Study | Ophthalmology | 1995 | 729 |